Clinical Trial Update: Preoperative Chemotherapy and Bevacizumab in Patients With Stage IB (>4 cm), II, or Select Stage III NSCLC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating preoperative chemotherapy with bevacizumab in select stages of non-small cell lung cancer was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2013-11-08